American Premium Mining : Financials

CONSOLIDATED BALANCE SHEET

(Unaudited)

For the Three Months

For the Three Months

Ended

Ended

March 31, 2022

March 31, 2021

ASSETS

Current Assets

Cash

$

213,387

$

48,930

Accounts Receivable

1,615

50,249

Note Receivable

299,798

289,798

Inventory

27,273

9,980

Other Current Assets

11,214

7,782

Total Current Assets

553,287

406,739

Other Assets

Property and equipment net of accumulated depreciation

3,899

9,748

Intangible assets, net of amortization

633

633

Total Other Assets

4,532

10,381

Total Assets

$

557,819

$

417,120

LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIENCY)

Current Liabilities

Accounts Payable

4,802

2,755

Accrued Expenses

470

159,787

Accrued interest payable

444,383

358,5386

Deferred Compensation

117,500

257,849

Stock and Note repurchase agreements

49,500

44,734

Stock due investors

60,000

60,000

Other liabilities to third parties

568,933

1,128,442

Bridge financing

175,000

175,000

Convertible Notes to third parties

1,162,931

988,572

Derivative liabilities on convertible notes

537,957

586,390

Common stock issuable

2,178

2,178

Total Current Liabilities

3,123,655

3,764,245

Total Liabilities

3,123,655

3,764,252

Stockholders' Equity (/Deficiency)

Preferred A Stock, $0.001 par value; 25,000,000 shares authorized,1,765,000 issued and outstanding at March

31, 2022 and 23,402,900 at March 31, 2021

1,765

23,403

Common stock, $0.0001 par value; 60,000,000,000 shares authorized, 4,608,588,983 issued and outstanding, at

March 31, 2022 and 1,614,663,998 at March 31, 2021

460,859

161,200

Additional paid-in capital

110,173,589

109,259,386

Accumulated deficit

(113,202,049)

(112,791,114)

Total Stockholders' Equity /(Deficiency)

(2,565,836)

(3,347,125)

Total Liabilities and Stockholders' Equity/( Deficiency)

$

557,819

$

17,120

For the Three Months Ended

For the Three Months Ended

March 31, 2022

March 31, 2021

Income

-

Sales

$

-

$

20,630

Cost of Goods Sold

-

5,045

Gross Profit

-

15,585

Operating Expenses

General and administrative

9,966

70,875

Professional Fees

35,975

2,087

Stock Based Compensation

-

240,000

Shareholder Expense

-

-

Total Operating Expenses

45,941

312,962

Loss from Operations

(45,941)

(297,377)

Other Income/ (Expense)

Derivative Liability

-

-

Gain on change in derivative value

-

(20,135)

Gain on write off of accrued expense

271,489

-

Interest expense

-

(35,561)

Total Other Income(Expense)

271,489

(55,696)

AS OF MARCH 31, 2022

Series A Preferred

Common Stock

Additional Paid-In

Shares

Amounts($)

Shares

Amount($)

Accumulated

Stockholders'

Capital ($)

Deficit ($)

Equity/(Deficit)

($)

Balance December 31,

24,068,400

24,068

754,067,423

75,407

108,307,964

(111,573,685)

(3,166,246)

2019

Common Shares

560,596,565

55,793

555,861

611,654

issued

Issuance of Preferred

10,000

10

(10)

(3,325)

(3,325)

shares for PSYN

Preferred shares

(500,000)

(500)

50,000,000

5,000

(1,800)

2,700

converted

Net loss for the year

-

(861,031)

(861,031)

ended December 31,

2020

Balance December 31,

23,578,400

23,578

1,364,663,988

136,200

108,862,015

(112,438,041)

(3,416,248)

2020

Issuance of Preferred

(650,000)

(650)

65,000,000

6,500

51,226

-

57,076

shares converted

Issuance of Preferred

174,500

175

470,000,000

47,000

534,237

581,412

shares converted

Issuance of common

124,741,935

12,474

(62,070)

(49,596)

shares debt conversion

Net loss for the year

-

-

-

-

(873,550)

(873,550)

ended December 31,

2021

Balance December 31,

23,102,900

23,103

2,024,405,923

202,171

109,385,408

(113,311,591)

(3,700,906)

2021

Issuance of common shar

2,584,183,060

258,418

788,181

1,046,599

debt conversion

Preferred shares returned

(5,453,900)

(5,453)

(5,453)

to Treasury

Preferred Shares reverse

(15,885,00)

(15,885)

(116,006)

(131,624)

split

Net income for the quarte

225,548

225,548

ended March 31, 2022

Balance March 31,

1,765,000

1,765

4,608,588,983

460,589

110,173,589

(113,202,049)

(2,565,836)

2022

See accompanying notes to condensed consolidated financial statement

For the Three Months

For the Three Months

Ended

Ended

March 31, 2022

March 31, 2021

$

225,548

$

(353,073)

240,000

25,278

20,133

2,924

-

-

(164,715)

688

(117,527)

35,310

(140,349)

-

-

-

-

4,766

(1,448)

(166,999)

(55,466)

-

-

-

-

55,000

-

461,239

-

(137,344)

-

52,234

17,450

376,129

72,450

209,130

16,984

4,257

31,946

$

213,387

$

48,930